Letter From The Editor

This week we have some interesting news about medications for obesity and their effects on diabetes. Our first article looks at the use of orlistat and lorcaserin and how waist circumference is affected while another article from EASD Barcelona examines the use of naltrexone and buproprion. The problem with all of these …

By the time that you read this newsletter we will either be in a funding gridlock or not, but regardless the Affordable Care Act will have started. A lot of attention has been on government programs but private health insurance is also affected by this new program. This week in …

Friday I was in Dallas to talk to care and case managers from Blue Cross of Texas. The topic was Hospital Readmissions and the impact on the coordination of care continuum. The focus of the presentation was how to keep patients from returning to the hospital. One of the most …

Last weekend, I spent some time with our president, Andrew Young, in Manhattan Beach. I got in some good quality time on the bike while Andrew was surfing in what I would swear was freezing water. Andrew has very well-controlled diabetes and to do this he often injects 6-8 times …

Over the years as an educator I have tried to find every advantage for my patients who have diabetes. For some reason many of my medical colleagues feel that if you tell a patient to do things the right way they will do it. Logic says that this won’t happen …

For those of us who are old enough to remember the first Star Trek, or for the rest of you who only know the original series from Nick at Nite reruns, Captain James Kirk would start the show in his rich deep voice by saying "Space: the final frontier. These are the …

Over the past few months we have brought you the latest information on SGLT2 Inhibitors, examining this new class of drugs from every angle including how they work, prescription insurance coverage, and both clinician and patient experience with this new medication. Jansen, the manufacturer of the only approved SGLT2 Inhibitor, …

As we move closer to the implementation of the Affordable Care Act, there are still many unanswered questions as to how things will work, challenges from all sides of the political spectrum and healthcare industry, and a lot of misinformation floating around as well. This week, in our Homerun Slides, we …

We have seen numerous studies demonstrating the value of resistance exercise for diabetes patients but often we only think of weights and machines and those methods rule out a lot of our patients. This week, Dr. Sheri Colberg brings us a primer on how all our patients can do some …

Years ago, when a patient was referred to the pharmacy for instructions on how to start insulin, we would add red food coloring to the saline making it easier to see the exact amount of liquid in the test syringe. Over time, I have thought about this idea and why …